Stopped: Intervention (GUT LINK Tool) was implemented outside of the context of a research study at our care centre, the QEII, as quality improvement. It became infeasible to consent all physicians to use the tool, and carry out this study.
It can be challenging for Primary Healthcare Providers (PHCPs) to differentiate between IBS and more serious illnesses involving the GI tract, such as Crohn's disease, ulcerative colitis, or cancer. To help with diagnosis and treatment of IBS, evidence-based guidelines have been developed. However, they are not commonly used in primary care practice and PHCPs and patients often feel that GI specialist evaluation and endoscopy is required. The development of care pathways and clinical practice guidelines is essential to support the investigation and management of digestive diseases, such as IBS. The current pilot study is designed to assess the implementation and early comparative effectiveness of a Clinical Care Pathway for lower GI tract symptoms.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of users
Timeframe: month 3
Number of users
Timeframe: month 6
Number of referrals
Timeframe: month 3
Number of referrals
Timeframe: month 6
Number of referrals per week
Timeframe: month 3
Number of referrals per week
Timeframe: month 6
Number of referrals per user
Timeframe: month 3
Number of referrals per user
Timeframe: month 6
Number of clicks per referral
Timeframe: month 3
Number of clicks per referral
Timeframe: month 6
Primary Healthcare Provider Satisfaction
Timeframe: baseline (month 0)
Primary Healthcare Provider Satisfaction
Timeframe: month 6